Skip to main content
Clinical Trials/NCT01786447
NCT01786447
Terminated
Not Applicable

Biomarkers of Brain Injury: Magnitude and Outcome of Mild and Moderate TBI

Banyan Biomarkers, Inc1 site in 1 country111 target enrollmentApril 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Brain Injuries, Traumatic
Sponsor
Banyan Biomarkers, Inc
Enrollment
111
Locations
1
Primary Endpoint
Assessment of biomarkers to identify patients with TBI from orthopedic controls
Status
Terminated
Last Updated
13 years ago

Overview

Brief Summary

The purpose of this study is to determine if specific brain injury biomarkers have utility as blood-based traumatic brain injury (TBI) diagnostic and monitoring tools. This will be accomplished by examining the relationships between potential serum-based TBI biomarkers and clinical measures of injury severity, occurrence of complications, and outcome, in subjects with mild or moderate TBI as well as in orthopedic control subjects.

Registry
clinicaltrials.gov
Start Date
April 2010
End Date
March 2011
Last Updated
13 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 18 years or older
  • CT scan as part of clinical evaluation
  • experienced some level of altered mental state at time of injury
  • determination of study eligibility within 4 hours of injury

Exclusion Criteria

  • Pregnant females
  • Anemia or significant blood loss (hemoglobin \< 12 mg/dL and/or hematocrit \< 35%, and/or clinical state requiring resuscitation with more than 6L of colloid or crystalloid fluid)
  • no clear history of trauma as primary event
  • previous history of stroke, or head injury requiring hospitalization
  • dementia or psychotic illness or neurological condition which may affect outcome
  • unable to speak or understand English
  • Orthopedic Control Group
  • Inclusion Criteria:
  • 18 years or older
  • Isolated extracranial orthopedic injury, including fractures

Outcomes

Primary Outcomes

Assessment of biomarkers to identify patients with TBI from orthopedic controls

Time Frame: 4 hours

Secondary Outcomes

  • Assessment of biomarkers to identify patients with brain lesions on CT scan(4 hours)

Study Sites (1)

Loading locations...

Similar Trials